*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
An innovative Impurity profiling method development for identification and quantitation of Bilastine and Montelukast Sodium with related impurities by RP-HPLC

Author: CHANDRA UMESH, KUMAR MANISH, GARG ARUN, SHARMA SHRESTHA, GUPTA PANKAJ
Abstract: A simple, rapid, precise and rugged reverse phase high performance liquid chromatographic (RP-HPLC) method has been developed for identification and quantitation of Bilastine and Montelukast active pharmaceutical ingredients along with related impurities from bulk and tablet dosage form. The separation of analytes and impurities peaks were achieved using a HPLC system equipped with photo diode array detector. A Hypersil BDS C-18 column used as stationary phase and 2mM ammonium acetate buffer: Acetonitrile used as a mobile phase operated in a gradient mode at flow rate of 0.8ml/min to 1.0ml/min with 30°C column temperature. Injection volume was 10 µl and chromatograms were analyzed at 275 nm with run time of 25 min. Under above conditions the retention time (RT) of Bilastine and Montelukast was 9.4 and 16.5 min respectively. Spiked Bilastine and Montelukast impurities i.e. BLS imidazole imp, BLS DEO imp, BLS TSO imp and MTK sulphoxide impurities were well separated at RT 1.1 min, 4.6 min, 13.5 min, and 14.3 min respectively. The calibration curve of Bilastine, Montelukast, Bilastine DEO impurity and Montelukast sulphoxide impurities were found linear with regression coefficient more than 0.999. Accuracy was determined by recovery studies and found between 95-105%. The sample was found stable in aqueous solution over 23 hours. In all the forced degradation conditions, Bilastine and Montelukast were detected along with known and unknown impurities, which were well separated from each others with high resolution. The recorded observations were proved that the proposed analytical method is reliable for quantitation and impurity profiling of Bilastine and Montelukast from bulk mixture and tablet dosage form.
Keyword: Bilastine, Montelukast, RP-HPLC, Impurity profiling, Forced degradation, Linearity
DOI: https://doi.org/10.31838/ijpr/2021.13.03.174
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free